Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Category > Report Information Email a colleague | Printer format

The Pharmaceutical Market: India

Espicom Healthcare Intelligence
September 30, 2009
206 Pages - Pub ID: ESPI2495302
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports


Countries covered: India

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.

Please Note: this is delivered as a Zip file.

Additional Information

India has a huge population in excess of one billion people and a growing middle class with access to high quality healthcare. Conversely, in this geographically vast country plagued by natural disasters, the majority of the population is both rural and poor and western style pharmaceuticals are not even an issue for millions of people.

India has an established domestic industry, responsible for around 8% of world pharmaceutical production. The larger domestic companies are striving to compete in the global market for both generics and original products.

The market is dominated by low priced, domestically-produced generics and relatively low per capita expenditure on pharmaceuticals.

The introduction of patent protection for pharmaceutical products from 1st January 2005 makes India a more attractive proposition for the international research-based industry, albeit in a highly competitive market.

The highly skilled domestic workforce offers good opportunities for outsourcing both research and production.

Related Reports:
Snapshots South Africa Pharmaceuticals 2009
Snapshots Poland Pharmaceuticals 2009
Snapshots Spain Pharmaceuticals 2009
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
Snapshots Hungary Pharmaceuticals 2009
Snapshots Venezuela Pharmaceuticals 2009
Thailand Pharmaceuticals and Healthcare Report Q1 2010
Australia Pharmaceuticals and Healthcare Report Q1 2010
Argentina Pharmaceuticals and Healthcare Report Q1 2010
Nigeria Pharmaceuticals and Healthcare Report Q1 2010

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 3